FindTrial
Sign In

COMPARISON OF THE TREATMENTOUTCOMES ON GUM DISEASE WITH THE USE OF PERIOGENâ?¢ AND BLOOD COMPONENT

COMPARATIVE EVALUATION OF PERIOGENâ?¢ AND PLATELET RICH FIBRIN IN THE TREATMENT OF MILLERâ??S CLASS I AND II GINGIVAL RECESSION DEFECTS.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017391
Enrollment
40
Registered
2019-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Periogenâ?¢: Periogenâ?¢ will be obtained from Virchow Biotech Private Limited, Hyderabad. It is commercially available as 0.5 ml solution of rhPDGF â??BB an

Sponsors

SAIRA SABA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1. Systemically healthy subjects. 2. Patients 18-40 years of age. 3. Bilateral Millerâ??s class I and II gingival recession. 4. Patients with >=1mm of width of keratinized gingiva. 5. Patients with a thick gingival biotype. 6. Presence of good oral hygiene maintenance. 7. Non smokers

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Presence of dehiscence or fenestration. 2. Malposed teeth. 3. Root caries. 4. History of any periodontal surgery in same area in the past 6 months. 5. Pregnant or lactating women. 6. Patients on medications.

Design outcomes

Primary

MeasureTime frame
Prior to surgery an acrylic stent will be fabricated on the patients cast for standardization of the measurements to be assessed and following clinical parameters will be assessed in millimetres using UNC-15 Probe: 1. Gingival recession depth. 2. Gingival recession width. 3. Probing depth. 4. Clinical attachment level. 5. Keratinized gingival width. Timepoint: AT BASELINE 3 MONTHS POST SURGERY 6 MONTHS POST SURGERY—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSAIRA SABA

THE OXFOR DENTAL COLLEGE & HOSPITAL

sunilc_06@hotmail.com9845203336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026